Infection and Immunity, January 1999, p. 271-278, Vol. 67, No. 1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Center for Microbial Pathogenesis and Department of Microbiology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York
Received 6 July 1998/Returned for modification 28 August 1998/Accepted 22 October 1998
Streptococcus gordonii is a frequent cause of infective
bacterial endocarditis, but its mechanisms of virulence are not well defined. In this study, streptococcal proteases were recovered from
spent chemically defined medium (CDM) and fractionated by ammonium
sulfate precipitation and by ion-exchange and gel filtration column
chromatography. Three proteases were distinguished by their different
solubilities in ammonium sulfate and their specificities for synthetic
peptides. One of the enzymes cleaved collagen analogs Gly-Pro
4-methoxy-
-naphthylamide, 2-furanacryloyl-Leu-Gly-Pro-Ala (FALGPA),
and p-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-Arg (pZ-peptide) and was released from the streptococci while complexed to
peptidoglycan fragments. Treatment of this protease with mutanolysin reduced its 180- to 200-kDa mass to 98 kDa without loss of enzymatic activity. The purified protease cleaved bovine gelatin, human placental
type IV collagen, and the A
chain of fibrinogen but not albumin,
fibronectin, laminin, or myosin. Enzyme activity was inhibited by
phenylmethylsulfonyl fluoride, indicating that it is a serine-type
protease. Maximum production of the 98-kDa protease occurred during
growth of S. gordonii CH1 in CDM containing 0.075% total
amino acids at pH 7.0 with minimal aeration. Higher initial
concentrations of amino acids prevented the release of the protease
without reducing cell-associated enzyme levels, and the addition of an
amino acid mixture to an actively secreting culture stopped further
enzyme release. The purified protease was stored frozen at
20°C for
several months or heated at 50°C for 10 min without loss of activity.
These data indicate that S. gordonii produces an
extracellular gelatinase/type IV collagenase during growth in medium
containing minimal concentrations of free amino acids. Thus, the
extracellular enzyme is a potential virulence factor in the amino
acid-stringent, thrombotic, valvular lesions of bacterial endocarditis.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|